Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (141-150 of 271) with videos related to

Pageof 28
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2022
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT StudySheldon R Morris, Sonia Jain, Jill Blumenthal, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.
AIDS Research and Human Retroviruses|September 1, 2012
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposureJose R Castillo-Mancilla, Jia-Hua Zheng, Joseph E Rower, et al.
AIDS Research and Human Retroviruses|October 4, 2018
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure ProphylaxisPeter L Havens, Ashutosh Tamhane, Charles B Stephensen, et al.
AIDS (London, England)|October 20, 2023
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppressionMargaret Lartey, Vincent J Ganu, Kenneth Tachi, et al.
AIDS (London, England)|September 14, 2018
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoringCatherine A Koss, Albert Y Liu, Jose Castillo-Mancilla, et al.
Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.
Plos One|February 24, 2023
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 studyGeetha Beauchamp, Sybil Hosek, Deborah J Donnell, et al.
Digital Health|June 1, 2022
Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in TaiwanHuei-Jiuan Wu, Yi-Fang Yu, Stephane Wen-Wei Ku, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United StatesCatherine A Koss, Sybil G Hosek, Peter Bacchetti, et al.
Pageof 28

Showing results (141-150 of 271) with videos related to

Sort By:
Pageof 28
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2022
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT StudySheldon R Morris, Sonia Jain, Jill Blumenthal, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.
AIDS Research and Human Retroviruses|September 1, 2012
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposureJose R Castillo-Mancilla, Jia-Hua Zheng, Joseph E Rower, et al.
AIDS Research and Human Retroviruses|October 4, 2018
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure ProphylaxisPeter L Havens, Ashutosh Tamhane, Charles B Stephensen, et al.
AIDS (London, England)|October 20, 2023
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppressionMargaret Lartey, Vincent J Ganu, Kenneth Tachi, et al.
AIDS (London, England)|September 14, 2018
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoringCatherine A Koss, Albert Y Liu, Jose Castillo-Mancilla, et al.
Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.
Plos One|February 24, 2023
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 studyGeetha Beauchamp, Sybil Hosek, Deborah J Donnell, et al.
Digital Health|June 1, 2022
Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in TaiwanHuei-Jiuan Wu, Yi-Fang Yu, Stephane Wen-Wei Ku, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United StatesCatherine A Koss, Sybil G Hosek, Peter Bacchetti, et al.
Pageof 28